Clinical Trial Update: Prevention of Renal and Vascular Endstage Disease Intervention Trial [Phase 3]

View source ↗

Summary

A Phase 3 trial focused on preventing end-stage renal disease and vascular complications has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Chronic Kidney Disease
• End-stage Renal Disease

Snippet

Sponsor: University Medical Center Groningen | Conditions: Microalbuminuria, Cardiovascular Diseases | Phase 3 | Status: COMPLETED